A Comparison of Tacrolimus and Cyclosporine in Liver Transplantation: Effects on Renal Function and Cardiovascular Risk Status
Open Access
- 1 May 2005
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 5 (5) , 1111-1119
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Evolution of liver transplantation in Europe: Report of the European Liver Transplant RegistryLiver Transplantation, 2003
- Chronic Renal Failure after Transplantation of a Nonrenal OrganNew England Journal of Medicine, 2003
- Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weightLiver Transplantation, 2001
- Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimusLiver Transplantation, 2001
- Tacrolimus conversion improves hyperlipidemic states in stable liver transplant recipientsLiver Transplantation, 2001
- The Effect of the Volume of Procedures at Transplantation Centers on Mortality after Liver TransplantationNew England Journal of Medicine, 1999
- TEN YEARS OF LIVER TRANSPLANTATIONTransplantation, 1997
- Evolution of cardiovascular risk after liver transplantation: A comparison of cyclosporine A and tacrolimus (FK506)Liver Transplantation, 1997
- Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejectionThe Lancet, 1994
- The effect of transplant center volume on cardiac transplant outcome. A report of the United Network for Organ Sharing Scientific Registry1994